First line chemotherapy for SCLC: The West of Scotland SCLC retrospective database

被引：0
|
作者：
Slater, S. [1 ]
McKay, S. [1 ]
MacLaren, V. [1 ]
Hicks, J. [1 ]
机构：
[1] West Scotland Canc Ctr, Glasgow, Lanark, Scotland
来源：
LUNG CANCER | 2014年 / 83卷
关键词：
D O I：
10.1016/S0169-5002(14)70179-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
178
引用
收藏
页码：S65 / S66
页数：2
相关论文
共 50 条
  • [1] Second line chemotherapy for recurrent SCLC: The West of Scotland SCLC retrospective database
    Slater, S.
    McKay, S.
    MacLaren, V.
    Hicks, J.
    LUNG CANCER, 2014, 83 : S64 - S65
  • [2] Second Line Chemotherapy in SCLC: The West of Scotland Experience
    Slater, S.
    Mckay, S.
    Pheeley, A.
    Mcloone, P.
    Steele, N.
    Maclaren, V.
    Hicks, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2338 - S2339
  • [3] TOPOTECAN AND CAV CHEMOTHERAPY FOR RECURRENT SCLC: THE WEST OF SCOTLAND EXPERIENCE
    Slater, S.
    Nowicki, S.
    Graham, J.
    Hicks, J.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S80 - S80
  • [4] RWD of Atezolizumab Plus Chemotherapy in First Line SCLC
    Cruz, P.
    Franco, L. Fernandez
    Montes, B. Riesco
    Falagan, S.
    Chara, L. E.
    Alonso, S. Simon
    Cerezo, S.
    Gutierrez-Sainz, L.
    Higuera, O.
    Villamayor, J.
    Moral, R. Galan
    Villa, J. C.
    Cabellos, R. Alvarez
    Rodriguez, A. K. Santos
    Bajo, R. Lopez
    Serrano, M.
    Portela, J.
    Munoz-Rodriguez, J. R.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S690 - S690
  • [5] INTENSIVE CHEMOTHERAPY IN SCLC
    KLASTERSKY, J
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (06): : 929 - 932
  • [6] First-line chemotherapy in metastatic small-cell lung cancer (SCLC)
    Wolf, M
    Tebbe, S
    Fink, T
    LUNG CANCER, 2004, 45 : S223 - S234
  • [7] Comparison of cisplatin-paclitaxel combination versus cisplatinetoposide as first line chemotherapy in SCLC
    Stathopoulos, G.
    Dimitroulis, J.
    Toubis, M.
    Stathopoulos, J.
    Koutantos, J.
    Rigatos, S. K.
    Athanasiadis, A.
    Antoniou, D.
    Giamboudakis, P.
    EJC SUPPLEMENTS, 2007, 5 (04): : 388 - 388
  • [8] Extended-stage SCLC (ES-SCLC) patients treated with first-line chemotherapy plus atezolizumab in Spain: Characteristics and outcomes
    Gomez-Mugarza, P.
    Laguna, S.
    Zapata, M.
    Prado, L. Fernandez
    Gimeno, J.
    Nuno, A.
    Galan, N.
    Arnaiz, I. Gil
    Artal-Cortes, A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S135 - S136
  • [9] A Retrospective Analysis of Adjuvant Chemotherapy in Patients with Completely Resected SCLC
    Tamura, Yosuke
    Fujisaka, Yasuhito
    Nakamura, Takahito
    Tsuji, Hiroyuki
    Matsunaga, Ninso
    Kawaguchi, Tetsufumi
    Imanishi, Masashi
    Yoshida, Syuhei
    Miyoshi, Keiji
    Ikeda, Soichiro
    Goto, Isao
    Hanafusa, Toshiaki
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S744 - S744
  • [10] First-Line Atezolizumab OK'd for SCLC
    Caruso, Catherine
    CANCER DISCOVERY, 2019, 9 (05) : 568 - 569
12345